https://medichelpline.com/clinical-feed/annals-of-internal-medicine-4-long-term-mpox-sequelae-11-to-18-months-after-acute-illness2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/annals-of-internal-medicine-21-misconceptions-about-whether-seeking-mental-health-care-jeopardizes-lawful-firearm-ownership-a-national-survey2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/annals-of-internal-medicine-11-grade-guidance-update-on-developing-good-practice-statements-in-guidelines2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-80-expanding-indications-for-stereotactic-radiosurgery-in-small-cell-lung-cancer-with-brain-metastases2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/annals-of-internal-medicine-18-actionable-and-evidence-based-practice-statements-can-we-do-better-2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-79-from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in-colorectal-cancer2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-94-reply-to-from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in-colorectal-cancer2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/annals-of-internal-medicine-28-be-better-at-benzos2026-01-20T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/kidney-international-82-parasympathetic-nerves-in-the-kidney-pelvis-contribute-to-blood-pressure-regulation2026-01-19T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-47-re-maria-de-santis-joan-palou-redorta-hiroyuki-nishiyama-et-al-durvalumab-in-combination-with-bcg-for-bcg-naive-high-risk-non-muscle-invasive-bladder-cancer-potomac-final-analysis-of-a-randomised-open-label-phase-3-trial-lancet-2025-406-2221-342026-01-19T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-34-biology-and-clinical-management-of-non-v600-braf-alterations-in-nsclc2026-01-19T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/kidney-international-81-sodium-glucose-transporter-2-inhibition-maintains-kidney-antibacterial-response-by-decreasing-complement-c1q2026-01-19T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/kidney-international-83-genotype-phenotype-characteristics-and-disease-progression-of-fan1-related-karyomegalic-tubulointerstitial-nephropathy2026-01-19T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-46-regional-node-positive-bladder-cancer-therapeutic-decisions-based-on-trial-results-in-perioperative-and-advanced-disease-settings2026-01-19T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-hepatology-84-is-liver-steatosis-a-disease-or-the-emperor-s-new-clothes-2026-01-17T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-48-bladder-preservation-therapy-in-combination-with-atezolizumab-and-radiation-therapy-bpt-art-for-invasive-bladder-cancer-final-analysis-from-a-multicentre-open-label-prospective-phase-2-trial2026-01-17T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-hepatology-85-thrombotic-microangiopathy-or-rejection-in-first-pig-to-human-patient-liver-xenotransplantation2026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-35-loss-of-payload-sensitivity-and-other-mechanisms-of-resistance-to-t-dxd-in-her2-mutant-nsclc-implications-for-subsequent-responsiveness-to-her2-tkis2026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/clinicaltrials-nct073490952026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-49-refining-salvage-radiotherapy-after-prostatectomy-positron-emission-tomography-guided-dose-escalation-in-empire-22026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-30-who-egypt-launches-a-new-national-training-of-trainers-programme-on-mass-casualty-management2026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-hepatology-86-is-partial-cure-a-realistic-endpoint-for-novel-hepatitis-b-therapy-2026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-29-message-for-world-leprosy-day-20262026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-36-message-for-world-leprosy-day-20262026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-37-who-egypt-launches-a-new-national-training-of-trainers-programme-on-mass-casualty-management2026-01-16T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-56-ending-the-controversy-around-pretreatment-dihydropyrimidine-dehydrogenase-dpd-dpyd-testing-heightens-the-controversy-over-appropriate-fluoropyrimidine-dosing2026-01-16T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-72-blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery2026-01-16T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-55-when-the-system-is-the-treatment-rethinking-nonpharmacologic-breakthroughs-in-oncology2026-01-16T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-93-reply-to-blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery2026-01-16T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/the-lancet-respiratory-medicine-15-eugenio-morelli-a-pioneer-of-pneumotherapy-and-his-portable-apparatus-for-artificial-pneumothorax2026-01-15T23:30:03.000Zdaily0.7https://medichelpline.com/clinical-feed/litfl-11-fernand-cathelin2026-01-15T16:05:00.000Zdaily0.7https://medichelpline.com/clinical-feed/cancer-cell-17-a-context-augmented-large-language-model-for-accurate-precision-oncology-medicine-recommendations2026-01-15T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-38-updated-who-manuals-provide-guidance-to-strengthen-foodborne-disease-surveillance-and-response-capacities-worldwide2026-01-15T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/cancer-cell-11-axes-of-biological-variation-in-diffuse-large-b-cell-lymphoma2026-01-15T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-31-updated-who-manuals-provide-guidance-to-strengthen-foodborne-disease-surveillance-and-response-capacities-worldwide2026-01-15T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-51-re-primary-retroperitoneal-lymph-node-dissection-in-marker-positive-clinical-stage-ii-non-seminomatous-germ-cell-tumours2026-01-14T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-52-the-discovery-of-prostate-specific-membrane-antigen-ligands-the-long-road-to-changes-in-clinical-practice-for-prostate-cancer2026-01-14T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-39-updated-who-manuals-released-to-help-countries-strengthen-foodborne-disease-surveillance-and-response2026-01-14T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-53-re-a-multicenter-randomized-phase-ii-trial-of-lenvatinib-plus-everolimus-versus-cabozantinib-in-patients-with-metastatic-clear-cell-rcc-that-progressed-on-pd-1-immune-checkpoint-inhibition-lencabo-2026-01-14T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/clinicaltrials-nct073015282026-01-14T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-50-the-hype-and-the-hope-where-do-we-stand-with-prostate-specific-membrane-antigen-targeted-fluorescence-guided-surgery-2026-01-14T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-11-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma2026-01-14T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-71-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma2026-01-14T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-70-reply-to-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma2026-01-14T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-10-reply-to-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma2026-01-14T08:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/endocrine-news-39-new-research-connections-how-dknet-allows-access-to-the-research-information-superhighway2026-01-13T13:27:03.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-40-cheaper-drinks-will-see-a-rise-in-noncommunicable-diseases-and-injuries2026-01-13T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/who-1-33-cheaper-drinks-will-see-a-rise-in-noncommunicable-diseases-and-injuries2026-01-13T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/journal-of-hepatology-88-reply-to-reassessing-the-l-reuteri-indole-3-lactic-acid-pathway-in-tace-related-liver-injury-2026-01-13T12:00:00.000Zdaily0.7https://medichelpline.com/clinical-feed/european-urology-55-re-open-versus-robotic-assisted-partial-nephrectomy-in-patients-with-intermediate-high-complexity-kidney-tumours-final-results-of-the-randomised-controlled-open-label-multicentre-trial-opera2026-01-13T12:00:00.000Zdaily0.7